IMMUCELL CORP /DE/ (ICCC)
About IMMUCELL CORP /DE/
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $27.6M
- Net income
- -$1.0M
- Total assets
- $42.5M
- Market cap
- $99.8M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $99.8M
- Shares outstanding
- 9.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 8, 1987
Immucell Corp /DE/ (ICCC) Stock Price
- Reported a net loss of $1.0M in FY2025.
- Trading 13% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review IMMUCELL CORP /DE/.
Write a review
News about IMMUCELL CORP /DE/
News & sentiment via Polygon.io
Immucell Corp /DE/: frequently asked questions
Is Immucell Corp /DE/ an American company?
Immucell Corp /DE/ is a US-based company headquartered in Portland, Maine, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Immucell Corp /DE/ headquartered?
Immucell Corp /DE/ is headquartered in Portland, Maine, United States.
Is Immucell Corp /DE/ publicly traded?
Yes — Immucell Corp /DE/ is a publicly traded company. Its stock trades under the ticker symbol ICCC on the NASDAQ.
What does Immucell Corp /DE/ do?
Immucell Corp /DE/ is an American Medical Devices company in the Health & Beauty sector.
